Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: An attractive vaccine target for aggressive pediatric cancer

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Scursoni, Alejandra M ^a   Galluzzo, Laura ^a   Camarero, Sandra ^a   Lopez, Jessica ^a   Lubieniecki, Fabiana ^a   Sampor, Claudia ^a   Segatori, Valeria I ^b   Gabri, Mariano R ^b   Alonso, Daniel F ^b   Chantada, Guillermo ^a   De Dávila, María Teresa G ^a  

^a Hospital de Pediatria SAMIC Prof Dr Juan P Garrahan   (Argentina)

^b UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GM3; MYC PROTEIN; N GLYCOLYLATED GANGLIOSIDE GM3; UNCLASSIFIED DRUG; CANCER VACCINE; DRUG DERIVATIVE; KI 67 ANTIGEN; N GLYCOLOYLNEURAMINYLLACTOSYLCERAMIDE; N-GLYCOLYLNEURAMINYLLACTOSYLCERAMIDE;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD CANCER; CHROMOSOME 1P; CHROMOSOME DELETION; CONTROLLED STUDY; CYTOPLASM; EWING SARCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; NEUROBLASTOMA; NEUROECTODERM TUMOR; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SCHOOL CHILD; CHEMISTRY; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; ONCOGENE MYC; PATHOLOGY;

ADOLESCENT; CANCER VACCINES; CHILD; CHILD, PRESCHOOL; G(M3) GANGLIOSIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; KI-67 ANTIGEN; NEUROECTODERMAL TUMORS;

EID: 81555226715     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/245181     Document Type: Article

References (34)

1. Irie R. F., Irie K., Morton D. L., A membrane antigen common to human cancer and fetal brain tissues Cancer Research 1976 36 9 3510 3517
2. Patra S. K., Dissecting lipid raft facilitated cell signaling pathways in cancer Biochimica et Biophysica Acta 2008 1785 2 182 206
3. Lopez P. H., Schnaar R. L., Gangliosides in cell recognition and membrane protein regulation Current Opinion in Structural Biology 2009 19 5 549 557
4. Kramer K., Kushner B., Heller G., Cheung N. K. V., Neuroblastoma metastatic to the central nervous system the memorial sloan-kettering cancer center experience and a literature review Cancer 2001 91 8 1510 1519 (Pubitemid 32319262)
5. Bordow S. B., Norris M. D., Haber P. S., Marshall G. M., Haber M., Prognostic significance of MYCN oncogene expression in childhood neuroblastoma Journal of Clinical Oncology 1998 16 10 3286 3294 (Pubitemid 28481623)
6. Yu A. L., Gilman A. L., Ozkaynak M. F., London W. B., Kreissman S. G., Chen H. X., Smith M., Anderson B., Villablanca J. G., Matthay K. K., Shimada H., Grupp S. A., Seeger R., Reynolds C. P., Buxton A., Reisfeld R. A., Gillies S. D., Cohn S. L., Maris J. M., Sondel P. M., Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma New England Journal of Medicine 2010 363 14 1324 1334
7. Modak S., Cheung N. K. V., Disialoganglioside directed immunotherapy of neuroblastoma Cancer Investigation 2007 25 1 67 77 (Pubitemid 46423592)
8. Fernandez L. E., Gabri M. R., Guthmann M. D., Alonso D. F., Gomez R. E., Gold S., Fainboim L., Gomez D. E., NGcGM3 ganglioside: a privileged target for cancer vaccines Clinical and Developmental Immunology 2010 2010 8
9. Scursoni A. M., Galluzzo L., Camarero S., Pozzo N., Gabri M. R., De Acosta C. M., Vzquez A. M., Alonso D. F., De Davila M. T. G., Detection and characterization of N-glycolyated gangliosides in Wilms tumor by immunohistochemistry Pediatric and Developmental Pathology 2010 13 1 18 23
10. Tangvoranuntakul P., Gagneux P., Diaz S., Bardor M., Varki N., Varki A., Muchmore E., Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid Proceedings of the National Academy of Sciences of the United States of America 2003 100 21 12045 12050 (Pubitemid 37271512)
11. Daz A., Alfonso M., Alonso R., Saurez G., Troche M., Catal M., Daz R. M., Pérez R., Vzquez A. M., Immune responses in breast cancer patients immunized with an anti-idiotype antibody mimicking NeuGc-containing gangliosides Clinical Immunology 2003 107 2 80 89 (Pubitemid 36579371)
12. Guthmann M. D., Castro M. A., Cinat G., Venier C., Koliren L., Bitton R. J., Vzquez A. M., Fainboim L., Cellular and humoral immune response to N-glycolyl-GM3 elicited by prolonged immunotherapy with an anti-idiotypic vaccine in high-risk and metastatic breast cancer patients Journal of Immunotherapy 2006 29 2 215 223
13. Alfonso M., Daz A., Hernndez A. M., Pérez A., Rodrguez E., Bitton R., Pérez R., Vzquez A. M., An anti-idiotype vaccine elicits a specific response to N-glycolyl sialic acid residues of glycoconjugates in melanoma patients Journal of Immunology 2002 168 5 2523 2529 (Pubitemid 34171859)
14. Alfonso S., Diaz R. M., De La Torre A., Santiesteban E., Aguirre F., Pérez K., Rodrguez J. L., Barroso M. D. C., Hernndez A. M., Toledo D., Gabri M. R., Alonso D. F., Viada C., Gmez R. E., Surez E., Vazquez A. M., Perez R., Macias A. E., 1E10 anti-idiotype vaccine in non-small cell lung cancer: experience in stage IIIb/IV patients Cancer Biology and Therapy 2007 6 12 1847 1852 (Pubitemid 351590395)
15. Hernndez A. M., Rodrguez N., Gonzlez J. E., Reyes E., Rondn T., Grin T., Macas A., Alfonso S., Vzquez A. M., Pérez R., Anti-NeuGcGM3 antibodies, actively elicited by idiotypic vaccination in nonsmall cell lung cancer patients, induce tumor cell death by an oncosis-like mechanism Journal of Immunology 2011 186 6 3735 3744
16. Matthay K. K., Villablanca J. G., Seeger R. C., Stram D. O., Harris R. E., Ramsay N. K., Swift P., Shimada H., Black C. T., Brodeur G. M., Gerbing R. B., Reynolds C. P., Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid New England Journal of Medicine 1999 341 16 1165 1173 (Pubitemid 29480654)
17. Joshi V. V., Peripheral neuroblastic tumors: pathologic classification based on recommendations of International Neuroblastoma Pathology Committee (modification of Shimada classification) Pediatric and Developmental Pathology 2000 3 2 184 199 (Pubitemid 30112464)
18. Alonso D. F., A novel hydrophobized GM3 ganglioside/Neisseria meningitidis outer-membrane-protein complex vaccine induces tumor protection in B16 murine melanoma International Journal of Oncology 1999 15 1 59 66
19. Remmele W., Stegner H. E., Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue Pathologe 1987 8 3 138 140
20. van Cruijsen H., Ruiz M., van der Valk P., de Gruijl T. D., Giaccone G., Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer BMC Cancer 2009 9, article no. 180
21. Kohla G., Stockfleth E., Schauer R., Gangliosides with O-acetylated sialic acids in tumors of neuroectodermal origin Neurochemical Research 2002 27 7-8 583 592
22. Simons K., Van Meer G., Lipid sorting in epithelial cells Biochemistry 1988 27 17 6197 6202
23. Lauc G., Heffer-Lauc M., Shedding and uptake of gangliosides and glycosylphosphatidylinositol-anchored proteins Biochimica et Biophysica Acta 2006 1760 4 584 602
24. Varki N. M., Varki A., Diversity in cell surface sialic acid presentations: implications for biology and disease Laboratory Investigation 2007 87 9 851 857 (Pubitemid 47267816)
25. Schlenzka W., Shaw L., Kelm S., Schmidt C. L., Bill E., Trautwein A. X., Lottspeich F., Schauer R., CMP-N-acetylneuraminic acid hydroxylase: the first cytosolic Rieske iron-sulphur protein to be described in Eukarya FEBS Letters 1996 385 3 197 200 (Pubitemid 26169815)
26. Irie A., Suzuki A., CMP-N-acetylneuraminic acid hydroxylase is exclusively inactive in humans Biochemical and Biophysical Research Communications 1998 248 2 330 333 (Pubitemid 28386421)
27. Marquina G., Waki H., Fernandez L. E., Kon K., Carr A., Valiente O., Perez R., Ando S., Gangliosides expressed in human breast cancer Cancer Research 1996 56 22 5165 5171 (Pubitemid 26383031)
28. Carr A., Mullet A., Mazorra Z., Vazquez A. M., Alfonso M., Mesa C., Rengifo E., Perez R., Fernandez L. E., A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors Hybridoma 2000 19 3 241 247 (Pubitemid 30622625)
29. Lipinski M., Braham K., Philip I., Neuroectoderm-associated antigens on Ewing's Sarcoma cell lines Cancer Research 1987 47 1 183 187 (Pubitemid 17002120)
30. Huang M., Lucas K., Current therapeutic approaches in metastatic and recurrent Ewing Sarcoma Sarcoma 2011 2011 5
31. Hettmer S., Malott C., Woods W., Ladisch S., Kaucic K., Biological stratification of human neuroblastoma by complex B pathway ganglioside expression Cancer Research 2003 63 21 7270 7276 (Pubitemid 37413467)
32. Kannagi R., Yin J., Miyazaki K., Izawa M., Current relevance of incomplete synthesis and neo-synthesis for cancer-associated alteration of carbohydrate determinants-Hakomori's concepts revisited Biochimica et Biophysica Acta 2008 1780 3 525 531 (Pubitemid 351381253)
33. Yin J., Hashimoto A., Izawa M., Miyazaki K., Chen G. Y., Takematsu H., Kozutsumi Y., Suzuki A., Furuhata K., Cheng F. L., Lin C. H., Sato C., Kitajima K., Kannagi R., Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells Cancer Research 2006 66 6 2937 2945
34. Livingston P. O., Approaches to augmenting the immunogenicity of melanoma gangliosides: from whole melanoma cells to ganglioside-KLH conjugate vaccines Immunological Reviews 1995 145 147 166